Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SIMICA

Financiado

Cerrado

Site selective protein modification chemistries for antibody drug conjugates AD...

Site selective protein modification chemistries for antibody drug conjugates ADCs SIMICA will provide IMM with the opportunity to integrate the European circle of research excellence institutions by cementing a sustainable science, technology and innovation network with internationally-leading organisations in... ver más

31/03/2023

iMM

800K€

Presupuesto del proyecto: 800K€

Líder del proyecto

INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANT... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 6 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2023-03-31

WIDESPREAD-03-2018: Twinning

I+D

Cerrada hace 6 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

6 Participantes

iMM

350.00K€ | Lider

CODIGO BARRAS NETWORKS

PERC

165.00K€ | Participante

Proyectos interesantes

DESARROLLO DE INMUNOTERAPIAS CONTRA EL CÁNCER...

Medical Technol...

Pharmaceutical...

676K€ Cerrado

Syndivia

Medical Technol...

Pharmaceutical...

71K€ Cerrado

IPT-2012-0198-090000

Medical Technol...

Biotechnology

3K€ Cerrado

ProteinConjugates

Medical Technol...

Chemical Engine...

3M€ Cerrado

DESARROLLO FARMACEUTICO DE UN AGENTE INMUNOMO...

Medical Technol...

Pharmaceutical...

3M€ Cerrado

MAGICBULLET

Medical Technol...

Chemical Engine...

4M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 45 meses Fecha Inicio: 2019-06-20
Fecha Fin: 2023-03-31

Líder del proyecto

INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANT... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 800K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto SIMICA will provide IMM with the opportunity to integrate the European circle of research excellence institutions by cementing a sustainable science, technology and innovation network with internationally-leading organisations in the field of protein drug-conjugates. The strategy of SIMICA is based on science- and innovation-driven clustering, and is focused on the exciting and upcoming area of designing and constructing the next generation of chemically-defined and innovative protein drug-conjugates for the targeted treatment of serious conditions such as cancer. The project will allow: i) strengthening the science and technology capacity of IMM and ii) leverage its research excellence and value creation through innovation with a beneficial and quantifiable impact for the entire research and development community at IMM, the Lisbon region and Portugal. The successful implementation of this strategy will rely on specific actions, including: 1) cementing of existing and the creation of new scientific, innovative and technical collaborations through short-term staff exchanges and short-term on-site training activities; 2) training, mentoring and international exposure of IMM’s young researchers and students; 3) building an innovation ecosystem centred at IMM; 4) igniting the entrepreneurial spirit among IMM’s research community; 5) increasing science awareness among the general public through targeted dissemination and communication activities; and 6) developing a sustainability strategy to sustain the cemented network beyond project terminus. Through the completion of these activities, IMM, supported by its twinning partners, is in the best temporal and spatial position to achieve an improved capability to compete for internationally competitive research funding and to access business stakeholders. By claiming its position in research and innovation networks IMM will effectively contribute to research excellence and value creation in health at European level.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores